Opinion · 1 Apr 2024
Conference abstract
Chiral drugs development: Safe medication for future
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In spite of US FDA and European agencies guidelines for marketing of optically active (homochiral) drugs, the racemic mixtures of chiral drugs are being sold and prescribed by clinicians in most of the Asian and African countries, resulting into some diseases and various side effects in human beings. It is a matter of great concern for all of us to have well developed, prosperous and healthy world. Therefore, there is a great need to design and develop economic, effective and selective methods of chiral drugs. The optically active drugs may be manufactured either by synthesis or separation of racemic mixture into optically active chiral drugs. To the best of my experience, the later approach is suitable and practical, which can be performed easily by HPLC. In this context, the development of HPLC methods for chiral separation at analytical level is the first step followed by the transfer of the developed conditions to preparative HPLC scale. The lecture will emphasize the need of the use chiral dugs. Besides, the stateof- art of chiral drugs development by HPLC will also be discussed. Efforts will be made to discuss chiral recognition mechanism.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 24 Dec 2021
Role of Chirality in Drugs Discovery and Development
Conference abstract · 24 Apr 2017
Chiral drugs development by chromatography
Research article · 30 Nov 2012
Development of normal phase chiral liquid chromatographic method for estimation of escitalopram oxalate and determination of R-citalopram enantiomer from escitalopram oxalate in bulk drug and tablet
Article · 19 Dec 2025
Drug Overdose Prevention: Strategies for Safe Medication Use and Public Health Protection
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Advancing Patient Safety Through Modern Pharmacovigilance Practices
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Imran Ali”

